AVXL – Anavex Life Sciences Corp.
Anavex Life Sciences Corp.AVXL
$8.27Name : Anavex Life Sciences Corp.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $706,025,664.00
EPSttm : -0.56
Anavex Life Sciences Corp.
$8.27
6.30%$0.49Float Short %
29.19
Margin Of Safety %
Put/Call OI Ratio
0.35
EPS Next Q Diff
-0.01
EPS Last/This Y
-0.04
EPS This/Next Y
2.91
Price
8.28
Target Price
34.33
Analyst Recom
1
Performance Q
-4.61
Relative Volume
1.21
Beta
0.67
Ticker: AVXL
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-05-09 | AVXL | 8.26 | 0.39 | 0.06 | 62663 |
| 2025-05-12 | AVXL | 8.53 | 0.38 | 0.28 | 63348 |
| 2025-05-13 | AVXL | 8.2 | 0.38 | 0.34 | 63578 |
| 2025-05-14 | AVXL | 8.17 | 0.38 | 0.18 | 63986 |
| 2025-05-15 | AVXL | 8.38 | 0.38 | 0.22 | 64077 |
| 2025-05-16 | AVXL | 8.31 | 0.38 | 0.42 | 64231 |
| 2025-05-19 | AVXL | 8.44 | 0.38 | 0.30 | 57574 |
| 2025-05-20 | AVXL | 7.53 | 0.37 | 0.22 | 58247 |
| 2025-05-21 | AVXL | 7.77 | 0.37 | 0.14 | 61334 |
| 2025-05-22 | AVXL | 7.68 | 0.37 | 0.10 | 62629 |
| 2025-05-23 | AVXL | 7.53 | 0.36 | 0.43 | 63122 |
| 2025-05-27 | AVXL | 7.36 | 0.36 | 0.07 | 63800 |
| 2025-05-28 | AVXL | 7.56 | 0.35 | 0.28 | 64973 |
| 2025-05-29 | AVXL | 7.63 | 0.35 | 0.15 | 65188 |
| 2025-05-30 | AVXL | 7.51 | 0.35 | 0.43 | 65321 |
| 2025-06-02 | AVXL | 7.55 | 0.35 | 0.57 | 65648 |
| 2025-06-03 | AVXL | 7.83 | 0.35 | 0.24 | 65695 |
| 2025-06-04 | AVXL | 7.72 | 0.35 | 0.01 | 65795 |
| 2025-06-05 | AVXL | 7.77 | 0.35 | 0.22 | 65980 |
| 2025-06-06 | AVXL | 8.27 | 0.35 | 0.56 | 66294 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-05-09 | AVXL | 8.25 | -15.4 | - | -0.65 |
| 2025-05-12 | AVXL | 8.55 | -15.4 | - | -0.65 |
| 2025-05-13 | AVXL | 8.10 | -15.4 | - | -0.65 |
| 2025-05-14 | AVXL | 8.16 | -15.4 | - | -0.65 |
| 2025-05-15 | AVXL | 8.37 | -3.6 | - | -0.65 |
| 2025-05-16 | AVXL | 8.32 | -3.6 | - | -0.56 |
| 2025-05-19 | AVXL | 8.44 | -3.6 | - | -0.56 |
| 2025-05-20 | AVXL | 7.53 | -3.6 | - | -0.56 |
| 2025-05-21 | AVXL | 7.76 | -3.6 | - | -0.56 |
| 2025-05-22 | AVXL | 7.68 | -3.6 | - | -0.56 |
| 2025-05-23 | AVXL | 7.53 | -3.6 | - | -0.56 |
| 2025-05-27 | AVXL | 7.37 | -3.6 | - | -0.56 |
| 2025-05-28 | AVXL | 7.57 | -3.6 | - | -0.56 |
| 2025-05-29 | AVXL | 7.63 | -3.6 | - | -0.56 |
| 2025-05-30 | AVXL | 7.53 | -3.6 | - | -0.56 |
| 2025-06-02 | AVXL | 7.55 | -3.6 | - | -0.56 |
| 2025-06-03 | AVXL | 7.84 | -3.6 | - | -0.56 |
| 2025-06-04 | AVXL | 7.72 | -3.6 | - | -0.56 |
| 2025-06-05 | AVXL | 7.78 | -3.6 | - | -0.56 |
| 2025-06-06 | AVXL | 8.28 | -3.6 | - | -0.56 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-05-09 | AVXL | 0.00 | 10.99 | 29.09 |
| 2025-05-12 | AVXL | 0.00 | 12.95 | 28.46 |
| 2025-05-13 | AVXL | 0.00 | 12.95 | 28.46 |
| 2025-05-14 | AVXL | 0.00 | 12.95 | 28.46 |
| 2025-05-15 | AVXL | 0.00 | 12.95 | 28.46 |
| 2025-05-16 | AVXL | 0.00 | 12.95 | 28.46 |
| 2025-05-19 | AVXL | 0.00 | 10.51 | 28.46 |
| 2025-05-20 | AVXL | 0.00 | 10.51 | 28.46 |
| 2025-05-21 | AVXL | 0.00 | 10.51 | 28.46 |
| 2025-05-22 | AVXL | 0.00 | 10.51 | 28.46 |
| 2025-05-23 | AVXL | 0.00 | 10.51 | 28.46 |
| 2025-05-27 | AVXL | 0.00 | 5.40 | 28.46 |
| 2025-05-28 | AVXL | 0.00 | 5.40 | 29.19 |
| 2025-05-29 | AVXL | 0.00 | 5.40 | 29.19 |
| 2025-05-30 | AVXL | 0.00 | 5.40 | 29.19 |
| 2025-06-02 | AVXL | 0.00 | 5.99 | 29.19 |
| 2025-06-03 | AVXL | 0.00 | 5.99 | 29.19 |
| 2025-06-04 | AVXL | 0.00 | 5.99 | 29.19 |
| 2025-06-05 | AVXL | 0.00 | 5.99 | 29.19 |
| 2025-06-06 | AVXL | 0.00 | 5.99 | 29.19 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.13
Avg. EPS Est. Current Quarter
-0.14
Avg. EPS Est. Next Quarter
-0.14
Insider Transactions
Institutional Transactions
5.99
Beta
0.67
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
10
Growth Score
21
Sentiment Score
88
Actual DrawDown %
73.7
Max Drawdown 5-Year %
-88.3
Target Price
34.33
P/E
Forward P/E
5.87
PEG
P/S
P/B
7.07
P/Free Cash Flow
EPS
-0.56
Average EPS Est. Cur. Y
-0.56
EPS Next Y. (Est.)
2.35
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.21
Return on Equity vs Sector %
-71.3
Return on Equity vs Industry %
-53.3
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.09
EBIT Estimation
Anavex Life Sciences Corp.Sector: Healthcare
Industry: Biotechnology
Employees: 42
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States. The company's lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. It also provides ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. Anavex Life Sciences Corp. was incorporated in 2004 and is headquartered in New York, New York.
stock quote shares AVXL – Anavex Life Sciences Corp. Stock Price stock today
news today AVXL – Anavex Life Sciences Corp. stock forecast ,stock prediction 2023 2024 2025
marketwatch AVXL – Anavex Life Sciences Corp. yahoo finance google finance
stock history AVXL – Anavex Life Sciences Corp. invest stock market
stock prices AVXL premarket after hours
ticker AVXL fair value insiders trading